Michael B. Chancellor 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-09 8:39 pm Purchase |
2025-04-07 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,641 4.800% |
1 (+0.00%) |
Filing |
| 2025-02-10 5:35 pm Unchanged |
2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,640 7.900% |
0 (Unchanged) |
Filing |
| 2025-01-30 5:28 pm Unchanged |
2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,640 10.000% |
0 (Unchanged) |
Filing |
| 2025-01-23 6:11 pm Purchase |
2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,640 11.500% |
209,640 (New Position) |
Filing |